3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
3
Colonic Neoplasms
3
Sarcopenia
2
Prostatic Neoplasms
2
Polycystic Ovary Syndrome
2
Diarrhea
2
Vaso-Occlusive Crises
1
Stomach Neoplasms
1
Seaweed Associated Changes in Healthy Subjects
1
Rectal Neoplasms
1
Proctitis
1
Neoplasms
1
Multiple Myeloma
1
Mucositis
1
Metabolic Syndrome
1
Malnutrition
1
Lymphoma
1
Liver Failure
1
Insulin Resistance
1
Hyperandrogenism
1
Head and Neck Neoplasms
1
Glucose Intolerance
1
Fibrosis
1
Colonic Polyps
1
Cholangiocarcinoma
1
Chemotherapy-related Diarrhea
1
Carcinoma, Hepatocellular
1
Anovulation
1
Anemia, Sickle Cell
1
Interventions
Metformin
30
Exercise
8
Pioglitazone
7
Inositol
6
Insulin
4
Acupuncture Therapy
4
High-Intensity Interval Training
3
Ethinyl Estradiol
3
salicylsalicylic acid
2
drospirenone and ethinyl estradiol combination
2
Water
2
Tablets
2
Sugars
2
Resistance Training
2
Preoperative Exercise
2
Folic Acid
2
Diet Therapy
2
Cyproterone Acetate
2
Caloric Restriction
2
Biguanides
2
ziprasidone
1
maltodextrin
1
lime
1
licogliflozin
1
exendin (9-39)
1
drospirenone
1
cinnulin PF
1
adrenosterone
1
Zoledronic Acid
1
World Health Organization oral rehydration solution
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Insulin Resistance
×
maltodextrin
×
Clear all
NCT03864068
2026-01-07
INSUPP-PCOS
Milton S. Hershey Medical Center
Phase 2
Completed
154 enrolled